Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study
Óscar Arrieta(Instituto Nacional de Cancerología), Carmen Aláez‐Verson(National Institute of Genomic Medicine)
Cited by 7
Related Papers
Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non–Small Cell Lung Cancer
|JAMA Oncology|2020|153
Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With <i>ALK</i>-Positive Advanced Non–Small-Cell Lung Cancer From the Phase III CROWN Study
|Journal of Clinical Oncology|2022|133
Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer
|Cancer Medicine|2020|80
Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes
|Clinical & Translational Oncology|2023|5